| News
Aging: The Tsunami for Healthcare
27.02.2019
Humanity is growing older. According to the UN the number of people in the world aged 60 years or over is projected to double to 2.1 billion by 2050. In developed countries, more than one third of the population will be over 60 by this time. The number of people over 80 will increase even faster to 434 million from 125 million in 2017. Meanwhile the working age population, who are needed to pay or provide support for the elderly, will only increase by about 25 percent over the same time.

These numbers make clear: The question mark in the title of the DayOne Experts Event “Aging – the game changer for healthcare?” is actually redundant. The game simply has to be changed! The speakers and panelists at the event that took place in Basel on February 26 agreed that healthcare as we know it will not be able to cope with the tsunami of aging. Under this perspective, aging not only represents a threat, but also an opportunity, for it will compel the industry to make the systematic changes that are required for the overall improvement of healthcare. Therefore aging can and should also be perceived as an interesting market for healthcare innovation.
But where to begin? This is what we learned from the speakers and panelists at the DayOne Expert Event:
1) Healthcare as we know it has been built for acute care: from infrastructure to career plans, research incentives and reimbursement schemes, healthcare professionals are trained to fix and rescue lives. But when it comes to long-term care and treatment this acute system is highly inefficient and costly. A possible way forward was presented by Mieke Deschodt from the University of Basel, who presented the novel care concept INSPIRE, which will be implemented in the canton of Baselland.
2) A big research effort is needed to better diagnose, treat and most of all prevent the disease burdens of an aging population. As Antonella Santuccione from the Woman’s Brain Project stated: It takes weeks to diagnose a tumor, but years to diagnose Alzheimer’s. And the significant differences in disease progression in terms of gender shows that a precision medicine approach is very much needed to make progress in treating disorders that are typical to aging.
3) The best way to cope with the tsunami of aging is actually by staying healthy – not only as long as possible but preferably to the end of life. In this perspective, we have to shift our mindset from neglecting or avoiding aging to aging successfully. And as the findings of the 90+ Study show, presented by geriatric neurologist Szofia Bullain, this will need a more holistic view on health, as psychological and social implications seem to count much more than physical activities and healthy nutrition alone for successful aging.
4) The right use and bold implementation of technology, most of all digital technology, will be crucial. But a lifelong approach will also be needed. Knowing the genetic preposition would allow for better monitoring and nudging an individual to healthy behavior, thereby preventing the occurrence of disease in old age starting from the very beginning of our lifespan. But to actually make this happen a first important step will be to set up a trusted platform which allows citizens to share their health data with all stakeholders.
A big thank you to all the speakers and panelists for sharing their great stories and very valuable insights:
Mieke Deschodt, University of Basel
Antonella Santuccione, Woman’s Brain Project and Roche Diagnostic
Szofia Bullain, MD Geriatric Neurologist
Manfred Eggersdorfer, DSM Nutritional Products
Andy Bushell, Novartis
Hansruedi Voelkle, EUPATI
Impressions
Slides presented at the Event
Presentation by Antonella Santuccione from Woman’s Brain Project and Roche Diagnostic
Presentation by Mieke Deschodt from the University of Basel
Presentatio by Szofia Bullain from MD Geriatric Neurologist
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
KUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read MoreUptownBasel joins IBM Quantum Network
UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...
Read MoreSouth Korean pharma firms show interest in the Basel Area
Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...
Read MoreGamma Technologies acquires ProFEMAG portfolio
The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...
Read More